AmerisourceBergen completes acquisition of WBA's Alliance Healthcare

AmerisourceBergen Corporation today (June 2) announced the completion of the acquisition of Alliance Healthcare, one of the largest pharmaceutical wholesalers in Europe.

The company acquired the majority of Walgreens Boots Alliance's (WBA) Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.

With this, the companies shared of providing a much "stronger support for pharmacies and pharmacists across the globe" and "integrated solutions for pharmaceutical manufacturers".

Julian Mount, managing director, Alliance Healthcare UK, felt joining AmerisourceBergen was "a positive step forward for Alliance Healthcare".

He added that it would allow his company "the chance to expand, evolve and innovate on each other’s best-in-class expertise and capabilities across the pharmaceutical supply chain.

"Our combined experience from pre-commercial and clinical trial, to broad market availability and patient adherence, will allow us to build new services and solutions that further support healthcare advancements around the world and enable us to better support our NHS and ultimately the patients they serve."

This acquisition will also help the WBA to increase focus on expanding its core retail pharmacy businesses and offer greater healthcare benefits to it patients and customers.

The companies have agreed to strengthen their strategic partnership by extending and expanding their commercial agreements further. They also announced "continuing the perusal of its purpose to create healthier future for everyone".

Welcoming the team of Alliance Healthcare, Steven H Collins, chairman, president and CEO of AmerisourceBergen, said: “This acquisition expands our reach and solutions in pharmaceutical distribution. It has added to the company’s breadth and depth of global manufacturer services.”

With this, the company now plans to advance its ability to provide innovative and global healthcare solutions.

“This transaction provides great benefit for both companies and is a logical step following the continued success of our long-term strategic relationship,” said Ornella Barra, chief operating officer, International, Walgreens Boots Alliance, Inc.

She added: “The Alliance Healthcare teams are joining a global pharmaceutical distribution leader and trusted partner in AmerisourceBergen; we look forward to continuing to work together as strategic partners.”

The two companies also shared plans to execute the expansion and extension of commercial agreements in order to drive incremental growth and synergies.

AmerisourceBergen concluded saying that, the Company continues to have strong performance across its businesses.